Promimic AB (publ) (STO:PRO)

Market Cap	184.20M -48.1%
Revenue (ttm)	45.21M +4.3%
Net Income	-7.74M
EPS	-0.41
Shares Out	18.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	625
Open	9.80
Previous Close	9.75
Day's Range	9.75 - 9.80
52-Week Range	7.70 - 19.45
Beta	-0.32
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 18, 2026

About Promimic AB

Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 17
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PRO

Financial Performance

In 2025, Promimic AB's revenue was 44.42 million, an increase of 1.01% compared to the previous year's 43.98 million. Losses were -8.75 million, -30.25% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error